Atlas Trials

A Phase II Study of Isolated Hepatic Perfusion (IHP) in Patients With Ocular Melanoma

Clinical trial NCT00062933 · COMPLETED

Trial details

NCT number
NCT00062933
Sponsor
National Cancer Institute (NCI)
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Melanoma
Start date
2003-06-01
Primary completion
2007-09-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.